Enhancing patient engagement: the influence of an in-consult patient decision aid on shared decision-making for lung tumour radiation - protocol for the randomised trial 'SDM Lung SBRT'

  • 0Department of Oncology, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark thomas.leth.fink@rsyd.dk.

|

|

Summary

This summary is machine-generated.

This study introduces a patient decision aid (PtDA) to enhance shared decision-making (SDM) in lung stereotactic body radiation therapy (SBRT). Engaging patients in treatment decisions for tumors near the thoracic wall is crucial for optimizing outcomes.

Area Of Science

  • Radiation Oncology
  • Clinical Decision-Making
  • Patient Engagement

Background

  • Shared decision-making (SDM) is increasingly promoted in healthcare.
  • Planning stereotactic body radiation therapy (SBRT) for lung tumors near the thoracic wall involves balancing tumor control with minimizing side effects like pain and fractures.
  • Currently, radiation oncologists often unilaterally decide on SBRT doses without patient input.

Purpose Of The Study

  • To introduce the protocol for the 'SDM Lung SBRT' randomized trial.
  • To evaluate the effectiveness of a patient decision aid (PtDA) in promoting patient engagement during SDM for lung SBRT.
  • To explore patient preferences in treatment decisions involving radiation dose escalation versus toxicity risk.

Main Methods

  • A randomized trial involving patients with lung tumors ≤1 cm from the thoracic wall.
  • Patients are randomized to consultations with or without a PtDA.
  • Treatment options include varying radiation doses (66 Gy/3 fractions, 45 Gy/3 fractions) or no treatment. The primary outcome is patient engagement measured by the OPTION-12 score.

Main Results

  • The study is designed to measure patient engagement using the OPTION-12 score.
  • Secondary outcomes include patient-reported quality of life and side effects.
  • Results will be disseminated through scientific meetings and peer-reviewed publications.

Conclusions

  • Engaging patients in SBRT treatment decisions for lung tumors near the thoracic wall is essential.
  • The PtDA aims to facilitate informed patient participation in complex treatment choices.
  • This trial will provide valuable data on SDM in the context of lung SBRT.